Hot Features
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins. It develops ORMD-0801, an oral insulin capsule, which is in phase III clinical trial for the treatment of individuals with diabete... Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins. It develops ORMD-0801, an oral insulin capsule, which is in phase III clinical trial for the treatment of individuals with diabetes. The company has license agreements with Oravax Medical Inc. to commercialize oral vaccines for COVID-19. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in New York, New York. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.13 | -3.29949238579 | 3.94 | 4.055 | 3.58 | 276730 | 3.76779611 | CS |
| 4 | -0.09 | -2.30769230769 | 3.9 | 5.01 | 3.58 | 236116 | 4.16199751 | CS |
| 12 | 0.465 | 13.9013452915 | 3.345 | 5.01 | 3.23 | 157335 | 3.93577289 | CS |
| 26 | 1.09 | 40.0735294118 | 2.72 | 5.01 | 2.66 | 186533 | 3.5787801 | CS |
| 52 | 1.54 | 67.8414096916 | 2.27 | 5.01 | 1.975 | 152150 | 3.10216582 | CS |
| 156 | -0.16 | -4.03022670025 | 3.97 | 5.01 | 1.67 | 164865 | 2.78916927 | CS |
| 260 | -8.19 | -68.25 | 12 | 31.54 | 1.67 | 474621 | 7.67963006 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.